Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Sonoma Pharmaceuticals, Inc.

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2022 Financial Results
From Sonoma Pharmaceuticals, Inc.
Via AccessWire
Tickers SNOA
Sonoma Pharmaceuticals and MicroSafe Group DMCC Announce that U.S. EPA has Added Nanocyn® Hospital-Grade Disinfectant to List N for Use Against COVID-19
From Sonoma Pharmaceuticals, Inc.
Via Business Wire
Tickers SNOA
Sonoma Pharmaceuticals and MicroSafe Group DMCC Announce EPA Approval for Nanocyn® Hospital-Grade Disinfectant in the U.S.
From Sonoma Pharmaceuticals, Inc.
Via Business Wire
Tickers SNOA
Sonoma Pharmaceuticals Launches New Urinary Tract Infection Product Through Distributors in New Zealand, Australia and South Africa
From Sonoma Pharmaceuticals, Inc.
Via Business Wire
Tickers SNOA
Sonoma Pharmaceuticals Reports Third Quarter FY 2022 Financial Results
From Sonoma Pharmaceuticals, Inc.
Via Business Wire
Tickers SNOA
Sonoma Pharmaceuticals Announces Expansion of its Partner Network for Oral and Dental Products in the U.S. and China
From Sonoma Pharmaceuticals, Inc.
Via Business Wire
Tickers SNOA
Sonoma Pharmaceuticals to Present at H.C. Wainwright BioConnect Virtual Conference January 10-13, 2022
From Sonoma Pharmaceuticals, Inc.
Via Business Wire
Tickers SNOA
Sonoma Pharmaceuticals Reports Second Quarter FY 2022 Financial Results
From Sonoma Pharmaceuticals, Inc.
Via Business Wire
Tickers SNOA
Sonoma Pharmaceuticals and Dyamed Biotech Announce Expanded Long-Term Partnership for New Territories and Products in Southeast Asia
From Sonoma Pharmaceuticals, Inc.
Via Business Wire
Tickers SNOA
Sonoma Pharmaceuticals and MicroSafe Group Announce that Nanocyn® Disinfectant & Sanitizer Has Been Approved by the Australia TGA with a 15 Second SARS-CoV-2 (COVID-19) Kill Time
From Sonoma Pharmaceuticals, Inc.
Via Business Wire
Tickers SNOA
Sonoma Pharmaceuticals Launches Its First Over-the-Counter Products in the U.S. on Amazon and a New Consumer-Focused Product on Amazon in Europe
From Sonoma Pharmaceuticals, Inc.
Via Business Wire
Tickers SNOA
Sonoma Pharmaceuticals Announces Expanded Dental Care Line with a New Product for Professional Care in the U.S. and a New Product for Professional and Consumer Care in Switzerland
From Sonoma Pharmaceuticals, Inc.
Via Business Wire
Tickers SNOA
Sonoma Pharmaceuticals Reports First Quarter 2022 Financial Results
From Sonoma Pharmaceuticals, Inc.
Via Business Wire
Tickers SNOA
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2021 Financial Results
From Sonoma Pharmaceuticals, Inc.
Via Business Wire
Tickers SNOA
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.